oleanolic acid has been researched along with hymecromone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Lu, MH; Xiao, W | 1 |
| Huang, S; Liu, D; Liu, M; Wu, J; Xia, C; Xie, H; Xiong, Y; Zhang, H | 1 |
3 other study(ies) available for oleanolic acid and hymecromone
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Comparison of the inhibition capability of oleanolic acid and betulinic acid towards drug-metabolizing enzymes.
Topics: Betulinic Acid; Drug Interactions; Glucuronosyltransferase; Humans; Hymecromone; Oleanolic Acid; Pentacyclic Triterpenes; Triterpenes | 2015 |
In vitro inhibition of UGT1A3, UGT1A4 by ursolic acid and oleanolic acid and drug-drug interaction risk prediction.
Topics: Drug Interactions; Glucuronosyltransferase; Hymecromone; Kinetics; Microsomes, Liver; Oleanolic Acid; Protein Isoforms; Triterpenes; Ursolic Acid | 2017 |